Integra Lifesciences Holdings Stock Technical Analysis
| IART Stock | USD 29.38 0.40 1.38% |
As of the 25th of April, Integra LifeSciences retains the Market Risk Adjusted Performance of (0.36), standard deviation of 2.55, and Risk Adjusted Performance of (0.12). Integra LifeSciences technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to interpolate data for thirteen technical drivers for Integra LifeSciences, which can be compared to its competitors. Please check out Integra LifeSciences risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Integra LifeSciences is priced fairly, providing market reflects its last-minute price of 29.38 per share. Given that Integra LifeSciences Holdings has information ratio of (0.24), we strongly advise you to confirm Integra LifeSciences's regular market performance to make sure the company can sustain itself at a future point.
Integra LifeSciences Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Integra, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to IntegraIntegra |
Integra LifeSciences Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 46.89 | Buy | 13 | Odds |
Most Integra analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Integra stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Integra LifeSciences, talking to its executives and customers, or listening to Integra conference calls.
Integra LifeSciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Integra LifeSciences Technical Analysis
The output start index for this execution was ten with a total number of output elements of fifty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Integra LifeSciences volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Integra LifeSciences Trend Analysis
Use this graph to draw trend lines for Integra LifeSciences Holdings. You can use it to identify possible trend reversals for Integra LifeSciences as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Integra LifeSciences price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Integra LifeSciences Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Integra LifeSciences Holdings applied against its price change over selected period. The best fit line has a slop of 0.23 , which may suggest that Integra LifeSciences Holdings market price will keep on failing further. It has 122 observation points and a regression sum of squares at 2012.65, which is the sum of squared deviations for the predicted Integra LifeSciences price change compared to its average price change.About Integra LifeSciences Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Integra LifeSciences Holdings on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Integra LifeSciences Holdings based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Integra LifeSciences price pattern first instead of the macroeconomic environment surrounding Integra LifeSciences. By analyzing Integra LifeSciences's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Integra LifeSciences's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Integra LifeSciences specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 (projected) | Dividend Yield | 0.41 | 0.43 | Price To Sales Ratio | 2.26 | 4.18 |
Integra LifeSciences April 25, 2024 Technical Indicators
Most technical analysis of Integra help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Integra from various momentum indicators to cycle indicators. When you analyze Integra charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.12) | |||
| Market Risk Adjusted Performance | (0.36) | |||
| Mean Deviation | 1.71 | |||
| Coefficient Of Variation | (489.07) | |||
| Standard Deviation | 2.55 | |||
| Variance | 6.48 | |||
| Information Ratio | (0.24) | |||
| Jensen Alpha | (0.65) | |||
| Total Risk Alpha | (0.88) | |||
| Treynor Ratio | (0.37) | |||
| Maximum Drawdown | 16.5 | |||
| Value At Risk | (3.46) | |||
| Potential Upside | 2.52 | |||
| Skewness | (2.18) | |||
| Kurtosis | 8.64 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Integra LifeSciences Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for Integra Stock analysis
When running Integra LifeSciences' price analysis, check to measure Integra LifeSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integra LifeSciences is operating at the current time. Most of Integra LifeSciences' value examination focuses on studying past and present price action to predict the probability of Integra LifeSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integra LifeSciences' price. Additionally, you may evaluate how the addition of Integra LifeSciences to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |
Is Integra LifeSciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Integra LifeSciences. If investors know Integra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Integra LifeSciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.60) | Earnings Share 0.84 | Revenue Per Share 19.248 | Quarterly Revenue Growth (0) | Return On Assets 0.0424 |
The market value of Integra LifeSciences is measured differently than its book value, which is the value of Integra that is recorded on the company's balance sheet. Investors also form their own opinion of Integra LifeSciences' value that differs from its market value or its book value, called intrinsic value, which is Integra LifeSciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Integra LifeSciences' market value can be influenced by many factors that don't directly affect Integra LifeSciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Integra LifeSciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Integra LifeSciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Integra LifeSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.